Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$1.155
▾0.02 (1.76%)
Last trade: 07/02, 10:38AM
Market cap
$851.38m
Market closed
Investor Presentations
Principal Activity
Mesoblast Limited (MSB) is an Australian company engaging in the development of biologic products for regenerative medicine. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp cells and Adipose cells. Its intellectual property covers applications in key markets including the United States, Europe, Japan and China.
Address
Level 38/55 Collins St, Melbourne VIC 3000, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$1.155
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia